2m 2m 2m 2m 2m 2m 2m
ACRIVON THERAPE (ACRV)
NASDAQ
$2.20-$0.01 (-0.63%)
Price as of Aug 21, 2026 7:56 PM EDT- $94.7MMarket Cap
- 62.50%1-Year Change
- BiotechnologyIndustry
ACRIVON THERAPE (ACRV)
$2.20-$0.01 (-0.63%)
ACRV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.21 | ||
Change | +$0.010 (+0.45%) | ||
Open | $2.21 | ||
High | $2.31 | ||
Low | $2.18 | ||
Previous Close | $2.20 | ||
Volume | 361,333 | ||
30-Day Average Volume | 403,206 | ||
1-Week Change | 13.33% | ||
1-Month Change | 26.29% | ||
1-Year Change | 62.50% | ||
3-Year Change | -80.11% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 42.9M | ||
Total Assets | $99.1M | ||
Market Cap | $94.7M | ||
Enterprise Value | $53.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.0M | ||
Free Cash Flow | -$14.9M | ||
EBIT | -$18.0M | ||
EBITDA | -$17.6M | ||
Net Working Capital | $80.0M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue